Change in Ocular Flora Resistance From Repeated Topical Antibiotic Use
NCT01181713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-03-18
Summary
The purpose of this study is to determine if antibiotic resistance of the ocular surface flora to the 4th generation fluoroquinolones will increase after repeated use of topical antibiotics for three days post intravitreal injection.
Conditions
- Increased Drug Resistance
- Infection Resistant to Quinolones and Fluoroquinolones
Sponsors & Collaborators
- collaborator INDUSTRY
-
Sunnybrook Health Sciences Centre
lead OTHER
Principal Investigators
-
Peter Kertes, MD, FRCSC · Sunnybrook Health Sciences Centre
-
Vivian T Yin, MD · University of Toronto
-
Daniel Weisbrod, MD, FRCSC · Sunnybrook Health Sciences Centre
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users
NCT06392438 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
NCT01881113 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
NCT03464435 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
NCT06451172 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Herpetic Eye Disease Study (HEDS) I
NCT00000138 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
NCT03230058 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comfort Associated With The Use Of Eyelid Cleansing Products Available For The Management Of Demodex Folliculorum
NCT03987230 ·Status: COMPLETED ·Phase: NA
-
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers
NCT06978244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis
NCT03105505 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
NCT00567918 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
NCT02432807 ·Status: COMPLETED ·Phase: PHASE3
-
OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
NCT05161208 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
NCT00357383 ·Status: COMPLETED ·Phase: PHASE1
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
NCT02132169 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
NCT01211327 ·Status: COMPLETED ·Phase: PHASE4
-
Non-invasive Diagnostics of Microbial Keratitis
NCT06364878 ·Status: RECRUITING
-
Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis
NCT05268718 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
NCT05127525 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers
NCT00651586 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583 ·Status: COMPLETED ·Phase: PHASE4